{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"50"}],"units":"Participants"}],"description":"The number of participants delaying the start of radiation therapy by more than 3 weeks due to complications as a result of surgical biopsy to obtain diagnostic tumor sample.","groups":[{"description":"Protocol treatment lasts approximately 52 weeks including a 4-week interim period once radiation therapy is completed and a maintenance phase (cycle duration=28 days).\n\nTreatment directed based on tumor biopsy results requires classification of patients into 1 of 4 potential cohorts: O6-methylguanine-DNA methyltransferase (MGMT) promoter methylation status (negative versus positive) and epidermal growth factor receptor (EGFR) overexpression status (negative versus positive).","id":"OG000","title":"All Biopsied Participants"}],"paramType":"COUNT_OF_PARTICIPANTS","populationDescription":"The analysis dataset is comprised of all enrolled participants who underwent stereotactic biopsy.","reportingStatus":"POSTED","timeFrame":"3 weeks","title":"Delay in Radiation Therapy Start","type":"SECONDARY","unitOfMeasure":"Participants"}